Changes in High Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun-Jae | - |
dc.contributor.author | Kwon, Sun U. | - |
dc.contributor.author | Park, Jong-Ho | - |
dc.contributor.author | Kim, Yong-Jae | - |
dc.contributor.author | Hong, Keun-Sik | - |
dc.contributor.author | Yu, Sungwook | - |
dc.contributor.author | Hwang, Yang-Ha | - |
dc.contributor.author | Lee, Ji Sung | - |
dc.contributor.author | Lee, Juneyoung | - |
dc.contributor.author | Rha, Joung-Ho | - |
dc.contributor.author | Heo, Sung Hyuk | - |
dc.contributor.author | Ahn, Sung Hwan | - |
dc.contributor.author | Seo, Woo-Keun | - |
dc.contributor.author | Park, Jong-Moo | - |
dc.contributor.author | Lee, Ju-Hun | - |
dc.contributor.author | Kwon, Jee-Hyun | - |
dc.contributor.author | Sohn, Sung-Il | - |
dc.contributor.author | Jung, Jin-Man | - |
dc.contributor.author | Kim, Hahn Young | - |
dc.contributor.author | Kim, Eung-Gyu | - |
dc.contributor.author | Kim, Sung Hun | - |
dc.contributor.author | Cha, Jae-Kwan | - |
dc.contributor.author | Park, Man-Seok | - |
dc.contributor.author | Nam, Hyo Suk | - |
dc.contributor.author | Kang, Dong-Wha | - |
dc.date.accessioned | 2021-08-31T15:02:37Z | - |
dc.date.available | 2021-08-31T15:02:37Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 2287-6391 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/58485 | - |
dc.description.abstract | Background and purpose Whether pharmacologically altered high-density lipoprotein cholesterol (HDL-C) affects the risk of cardiovascular events is unknown. Recently, we have reported the Prevention of Cardiovascular Events in Asian Patients with Ischaemic Stroke at High Risk of Cerebral Haemorrhage (PICASSO) trial that demonstrated the non-inferiority of cilostazol to aspirin and superiority of probucol to non-probucol for cardiovascular prevention in ischemic stroke patients (clinicaltrials.gov: NCT01013532). We aimed to determine whether on-treatment HDL-C changes by cilostazol and probucol influence the treatment effect of each study medication during the PICASSO study. Methods Of the 1,534 randomized patients, 1,373 (89.5%) with baseline cholesterol parameters were analyzed. Efficacy endpoint was the composite of stroke, myocardial infarction, and cardiovascular death. Cox proportional hazards regression analysis examined an interaction between the treatment effect and changes in HDL-C levels from randomization to 1 month for each study arm. Results One-month post-randomization mean HDL-C level was significantly higher in the cilostazol group than in the aspirin group (1.08 mmol/L vs. 1.00 mmol/L, P<0.001). The mean HDL-C level was significantly lower in the probucol group than in the non-probucol group (0.86 mmol/L vs. 1.22 mmol/L, P<0.001). These trends persisted throughout the study. In both study arms, no significant interaction was observed between HDL-C changes and the assigned treatment regarding the risk of the efficacy endpoint. Conclusions Despite significant HDL-C changes, the effects of cilostazol and probucol treatment on the risk of cardiovascular events were insignificant Pharmacologically altered HDL-C levels may not be reliable prognostic markers for cardiovascular risk. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN STROKE SOC | - |
dc.subject | CEREBRAL-HEMORRHAGE PICASSO | - |
dc.subject | PHOSPHODIESTERASE INHIBITOR | - |
dc.subject | CAROTID ATHEROSCLEROSIS | - |
dc.subject | HDL CHOLESTEROL | - |
dc.subject | ISCHEMIC-STROKE | - |
dc.subject | STATIN THERAPY | - |
dc.subject | PROBUCOL | - |
dc.subject | PREVENTION | - |
dc.subject | DISEASE | - |
dc.subject | TRIGLYCERIDES | - |
dc.title | Changes in High Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yu, Sungwook | - |
dc.contributor.affiliatedAuthor | Lee, Juneyoung | - |
dc.contributor.affiliatedAuthor | Jung, Jin-Man | - |
dc.identifier.doi | 10.5853/jos.2019.02551 | - |
dc.identifier.scopusid | 2-s2.0-85079448543 | - |
dc.identifier.wosid | 000512366600009 | - |
dc.identifier.bibliographicCitation | JOURNAL OF STROKE, v.22, no.1, pp.108 - 118 | - |
dc.relation.isPartOf | JOURNAL OF STROKE | - |
dc.citation.title | JOURNAL OF STROKE | - |
dc.citation.volume | 22 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 108 | - |
dc.citation.endPage | 118 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002555817 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | CEREBRAL-HEMORRHAGE PICASSO | - |
dc.subject.keywordPlus | PHOSPHODIESTERASE INHIBITOR | - |
dc.subject.keywordPlus | CAROTID ATHEROSCLEROSIS | - |
dc.subject.keywordPlus | HDL CHOLESTEROL | - |
dc.subject.keywordPlus | ISCHEMIC-STROKE | - |
dc.subject.keywordPlus | STATIN THERAPY | - |
dc.subject.keywordPlus | PROBUCOL | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | TRIGLYCERIDES | - |
dc.subject.keywordAuthor | Cholesterol, HDL | - |
dc.subject.keywordAuthor | Secondary prevention | - |
dc.subject.keywordAuthor | Cilostazol | - |
dc.subject.keywordAuthor | Probucol | - |
dc.subject.keywordAuthor | Cholesterol ester transfer proteins | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.